| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/20/1999 | US5925772 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 07/20/1999 | US5925744 Macrocyclic compound for sequence cleavage of rna |
| 07/20/1999 | US5925730 Decapeptide gonadotrophin releasing hormone antagonists; for antifertility agents especially for males; precocious puberty; dysmenorrhea; antitumor/anticarcinogenic agents; endometriosis |
| 07/20/1999 | US5925729 Isolated amino acid sequence encoding antigen; use as agent for treating the cancer for which the antigen is a ?marker?, as well as in various diagnostic approaches to oncology |
| 07/20/1999 | US5925671 Administering to mammals an isocoumarin compound from fermentation of microorganisms like bacillus |
| 07/20/1999 | US5925665 Imidazoline compounds |
| 07/20/1999 | US5925661 Nervous system disorders |
| 07/20/1999 | US5925660 Enzyme inhibitors for phosphatase |
| 07/20/1999 | US5925642 Pyridopyrimidines |
| 07/20/1999 | US5925639 Keto amide derivatives useful as farnesyl protein transferase inhibitors |
| 07/20/1999 | US5925624 Antiinflammatory agents treating patients with inflammatory conditions susceptible to leukocyte-induced tissue damage |
| 07/20/1999 | US5925619 Formulation for peptide release |
| 07/20/1999 | US5925568 It is also useful to be able to harvest haematopoietic cells prior to chemotherapy or radiotherapy, thus protecting them from the effects of this therapy; after therapy, the cells can be returned to the patient. |
| 07/20/1999 | US5925557 This invention relates generally to the field of protein kinases, oncogenes and oncoproteins and, specifically, to a protein kinase which phosphorylates and potentiates the activity of c-fos. |
| 07/20/1999 | US5925547 Nucleic acid encoding novel protein domain which binds tyrosine phosphorylated proteins |
| 07/20/1999 | US5925539 Human pelota homolog |
| 07/20/1999 | US5925516 Medicaments for the treatment of papillomavirus diseases |
| 07/20/1999 | US5925362 Method to elicit an antitumor response with human prostate-specific antigen |
| 07/20/1999 | CA2163837C Crystalline paclitaxel hydrates |
| 07/20/1999 | CA2137638C Anti gangliosides monoclonal antibodies and their use in the specific active immunotherapy of malignant tumors |
| 07/20/1999 | CA2082394C Pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 07/15/1999 | WO1999035292A1 Compositions and methods for treating cells having double minute dna |
| 07/15/1999 | WO1999035277A2 Recombinant, active caspases and uses thereof |
| 07/15/1999 | WO1999035253A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035252A2 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035246A1 Novel steroid-activated nuclear receptors and uses therefor |
| 07/15/1999 | WO1999035168A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035166A1 Compounds and methods for modulating occludin related tissue permeability |
| 07/15/1999 | WO1999035158A1 36 human secreted proteins |
| 07/15/1999 | WO1999035153A1 Anthracycline glycosides |
| 07/15/1999 | WO1999035150A1 Synthesis of combretastatin a-4 prodrugs and trans-isomers thereo f |
| 07/15/1999 | WO1999035146A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 07/15/1999 | WO1999035124A1 Matrix metalloprotease inhibitors |
| 07/15/1999 | WO1999034824A2 Tumour vaccines for muc1-positive carcinomas |
| 07/15/1999 | WO1999034806A1 KINESIN MOTOR MODULATORS DERIVED FROM THE MARINE SPONGE $i(ADOCIA) |
| 07/15/1999 | WO1999034796A1 Synergistic antitumor composition containing a naphthalensulphonic acid derivative |
| 07/15/1999 | WO1999034788A1 Synthesis of phenstatin and prodrugs thereof |
| 07/15/1999 | WO1999034784A2 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 07/15/1999 | WO1999034783A1 USE OF PPAR-η ACTIVATORS IN DERMATOLOGY |
| 07/15/1999 | WO1999034779A1 Magnetically responsive composition |
| 07/15/1999 | WO1999034763A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis |
| 07/15/1999 | WO1999025375A8 DIRECT CYTOTOXIC ACTIVITY BY ANTI-hCG MONOCLONAL ANTIBODIES |
| 07/15/1999 | WO1999013095A9 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
| 07/15/1999 | WO1998042855A9 Rapid production of autologous tumor vaccines by using hsv amplicon vectors |
| 07/15/1999 | DE19813759C1 Inducing a natural killer cell immune response ex vivo |
| 07/15/1999 | CA2351624A1 Compounds and methods for modulating tissue permeability |
| 07/15/1999 | CA2318380A1 Compositions and methods for treating cells having double minute dna |
| 07/15/1999 | CA2318369A1 Recombinant, active caspases and uses thereof |
| 07/15/1999 | CA2317702A1 36 human secreted proteins |
| 07/15/1999 | CA2317382A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316973A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316864A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2314510A1 Synthesis of phenstatin and prodrugs thereof |
| 07/15/1999 | CA2245909A1 Novel compounds |
| 07/14/1999 | EP0928788A1 Imidazolidin-4-one derivatives useful as anticancer agents |
| 07/14/1999 | EP0928609A2 Use of sulphamate derivatives as steroid sulphatase inhibitors |
| 07/14/1999 | EP0928340A1 Invasion-inducing agents and invasion-inhibitors for use in wound healing and cancer |
| 07/14/1999 | EP0928337A1 A human protein tyrosine kinase |
| 07/14/1999 | EP0928328A1 Methods for culturing cells |
| 07/14/1999 | EP0928291A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 07/14/1999 | EP0928203A1 Gene therapy for inhibition of angiogenesis |
| 07/14/1999 | EP0928200A2 Therapeutic combinations of rar antagonists and rxr agonists |
| 07/14/1999 | EP0928194A1 Compositions and methods for administering integrin receptor antagonists |
| 07/14/1999 | EP0759079B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1-BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel-III) |
| 07/14/1999 | EP0754234B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1 BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICE rel-II) |
| 07/14/1999 | EP0721336B1 Benzazole compounds for use in therapy |
| 07/14/1999 | EP0648205B1 Peptidyl derivatives as metalloproteinase inhibitors |
| 07/14/1999 | EP0574414B1 LIGAND GROWTH FACTORS THAT BIND TO THE erbB-2 RECEPTOR PROTEIN AND INDUCE CELLULAR RESPONSES |
| 07/14/1999 | EP0531434B1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 07/14/1999 | CN1222911A Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| 07/14/1999 | CN1222384A Anticarcinogen for liver cancer |
| 07/14/1999 | CN1222367A Preparation of medicine for curing burns and scalds |
| 07/14/1999 | CN1222364A Serial medicines for curing cancer through oral taking, dressing and medicated diet and preparation thereof |
| 07/14/1999 | CN1222356A New application of angelic polysaccharide and angelic lactone as biological reaction regulator to cure tumor |
| 07/13/1999 | US5922877 Methods of preparing and purifying 9-nitro-20-camptothecin |
| 07/13/1999 | US5922853 Human pelota homolog |
| 07/13/1999 | US5922847 Exposure to antibody or fragments binding to epitope on receptor recognized by the factor, separating binding cells |
| 07/13/1999 | US5922846 Process for refolding recombinantly produced TGF-β-like proteins |
| 07/13/1999 | US5922845 Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies |
| 07/13/1999 | US5922836 Mammaglobin antigens |
| 07/13/1999 | US5922761 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 07/13/1999 | US5922754 Pharmaceutical compositions containing paclitaxel |
| 07/13/1999 | US5922750 Terpenoidic derivatives useful as antitumor agents |
| 07/13/1999 | US5922747 Comprising testosterone reductase used for treatment of acne, alopacia, skin and glandular disorders, prostatic hypertropy, |
| 07/13/1999 | US5922741 5-aminopyrazoles useful as tyrosine kinase inhibitors |
| 07/13/1999 | US5922740 Antiinflammatory agents |
| 07/13/1999 | US5922711 Antiallergens, antiinflammatory agents, autoimmune diseases, shock or analgesics |
| 07/13/1999 | US5922595 Cyclic GMP phosphodiesterase |
| 07/13/1999 | US5922590 Hic-1 is a marker which can be used diagnostically, prognostically and therapeutically over the course of such disorders. |
| 07/13/1999 | US5922582 Indole alkaloid type compound 0089-D |
| 07/13/1999 | US5922572 Polynucleotides encoding haemopoietic maturation factor |
| 07/13/1999 | US5922566 Polynucleotide |
| 07/13/1999 | US5922350 Dehydration in presence of sugars present at a protectiveconcentration on both inside and outside surfaces; liposomeshave ion concentration gradient capable of generatingtransmember potential to load charged material |
| 07/13/1999 | US5922321 Prostate-specific kallikrein |
| 07/13/1999 | US5922318 Drug protein |
| 07/13/1999 | US5922302 Detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| 07/13/1999 | CA2129144C Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives |
| 07/13/1999 | CA1340641C Recombinant lymphotoxin |
| 07/08/1999 | WO1999034004A2 Metastatic breast and colon cancer regulated genes |
| 07/08/1999 | WO1999033981A2 Human signal peptide-containing proteins |